WO2022171342 - SYRINGE CARRIERS
National phase entry:
Publication Number
WO/2022/171342
Publication Date
18.08.2022
International Application No.
PCT/EP2021/086939
International Filing Date
21.12.2021
Title **
[English]
SYRINGE CARRIERS
[French]
SUPPORTS DE SERINGUE
Applicants **
SHL MEDICAL AG
Gubelstrasse 22
PO Box 7710
6302 Zug, CH
Inventors
CARLSSON, Daniel
c/o SHL Medical AB
PO Box 1240, Augustendalsvägen 7
131 28 Nacka Strand, SE
YIN, Ming-Ting
No 36 Liufu Rd
Taoyuan City, 338, TW
BOSTRÖM, Anders
c/o SHL Medical AB
PO Box 1240, Augustendalsvägen 7
131 28 Nacka Strand, SE
SU, Chia-Hsin
No 36 Liufu Rd, Luzhu District
Taoyuan City, 338, TW
CHIOU, Meng-Jhen
No 36 Liufu Rd, Luzhu District
Taoyuan City, 338, TW
Priority Data
63/149,380
15.02.2021
US
63/153,408
25.02.2021
US
63/158,580
09.03.2021
US
63/162,601
18.03.2021
US
63/178,577
23.04.2021
US
21187327.8
23.07.2021
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1492 | |
| EPO | Filing, Examination | 4877 | |
| Japan | Filing | 587 | |
| South Korea | Filing | 736 | |
| USA | Filing, Examination | 3910 |
Total: 11602 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The medicament delivery device sub-assembly comprises a tubular housing (30), a tubular syringe carrier (130) inside the housing (30) and a syringe (50) inside the syringe carrier (130). The syringe (50) comprises a needle shield (58, 60) and a medicament container (52) comprising a shoulder (64). The housing (30) comprises a flexible arm (320) extending in the axial direction (13) relative to the longitudinal axis (12), the flexible arm (320) comprising an inwardly extending protrusion (322)- The inwardly extending protrusion (322) is arranged in a gap between the shoulder (64) and the needle shield (58, 60). The syringe carrier (130) comprises a proximal portion and a distal portion, and the proximal portion is arranged adjacent to the flexible arm (320) of the housing (30) so that movement of the flexible arm (320) of the housing (30) in a radial direction (17) relative to the longitudinal axis (12) is restricted by the proximal portion of the syringe carrier (130).[French]
La présente invention concerne un sous-ensemble de dispositif d'administration de médicament qui comprend un boîtier tubulaire (30), un support de seringue tubulaire (130) disposé à l'intérieur du boîtier (30) et une seringue (50) disposée à l'intérieur du support de seringue (130). La seringue (50) comprend un protecteur d'aiguille (58, 60) et un récipient de médicament (52) comprenant un épaulement (64). Le boîtier (30) comprend un bras flexible (320) s'étendant dans la direction axiale (13) par rapport à l'axe longitudinal (12), le bras flexible (320) comprenant une saillie s'étendant vers l'intérieur (322) et disposée dans un espace entre l'épaulement (64) et le protecteur d'aiguille (58, 60). Le support de seringue (130) comprend une partie proximale et une partie distale, et la partie proximale est disposée de manière adjacente au bras flexible (320) du boîtier (30) de sorte que le mouvement du bras flexible (320) du boîtier (30) dans une direction radiale (17) par rapport à l'axe longitudinal (12) est limité par la partie proximale du support de seringue (130).